Mayo Clinic. (2024). Mammary Duct Ectasia: Symptoms & Causes. Retrieved from https://www.mayoclinic.org/diseases-conditions/mammary-duct-ectasia/symptoms-causes/syc-20374801
U.S. Food & Drug Administration. (2024). Step 3: Clinical Research. https://www.fda.gov/patients/drug-development-process/step-3-clinical-research#:~:text=Study%20Participants%3A%2020%20to%20100,people%20with%20the%20disease%2Fcondition.&text=During%20Phase%201%20studies%2C%20researchers,condition%20participate%20in%20Phase%201.
Skin Cancer Foundation. (2024). Annual Skin Exams. https://www.skincancer.org/early-detection/annual-exams
Cleveland Clinic. (2024). Breast Ultrasound. https://my.clevelandclinic.org/health/diagnostics/21496-breast-ultrasound
Cleveland Clinic. (2024). Cytokine Blood Markers. https://my.clevelandclinic.org/health/body/24585-cytokines
Mayo Clinic. (2024). C-reactive protein test. https://www.mayoclinic.org/tests-procedures/c-reactive-protein-test
NIHR. (2024). Inflammatory Markers Explained. [https://arc-w.nihr.ac.uk/news/inflammatory-markers-explained
Cleveland Clinic. (2024). Cytokine Blood Markers. https://my.clevelandclinic.org/health/body/24585-cytokines
Guide to clinical trials - gilead clinical trials. Guide To Clinical Trials - Gilead Clinical Trials. (n.d.). https://www.gileadclinicaltrials.com/en/understandingclinicaltrials?utm_medium=paid&utm_source=google&gad_source=1&gclid=Cj0KCQiA0MG5BhD1ARIsAEcZtwR_-gZLgS2dlXY9tHls76l4g2kskiMICnJdabnUgMoG7j0q5Lgii90aAnaLEALw_wcB&gclsrc=aw.ds
Centers for Disease Control and Prevention. (n.d.). Breast cancer risk factors. Centers for Disease Control and Prevention. https://www.cdc.gov/breast-cancer/risk-factors/index.html#:~:text=Most%20breast%20cancers%20are%20found,factors%20have%20the%20same%20effect
How to conduct a clinical trial risk assessment. Clinical Trials Hub. (2024, August 4). https://clinicaltrialshub.htq.org.au/blog/how-to-conduct-a-clinical-trial-risk-assessment/
Center for Devices and Radiological Health. (n.d.). Ide informed consent. U.S. Food and Drug Administration. https://www.fda.gov/medical-devices/investigational-device-exemption-ide/ide-informed-consent
Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ, 340, c332. https://doi.org/10.1136/bmj.c332
Day, S. J., & Altman, D. G. (2000). Statistics notes: blinding in clinical trials and other studies. BMJ, 321(7259), 504. https://doi.org/10.1136/bmj.321.7259.504
Boutron, I., Guittet, L., Estellat, C., Moher, D., Hróbjartsson, A., & Ravaud, P. (2007). Reporting methods of blinding in randomized trials assessing nonpharmacological treatments. PLoS Medicine, 4(2), e61. https://doi.org/10.1371/journal.pmed.0040061
International Conference on Harmonisation. (2016). Guideline for Good Clinical Practice E6(R2). https://www.ich.org/page/efficacy-guidelines
Baigent, C., Harrell, F. E., Buyse, M., Emberson, J. R., & Altman, D. G. (2008). Ensuring trial validity by data quality assurance and diversification of monitoring methods. Clinical Trials, 5(1), 49-55. https://doi.org/10.1177/1740774507087554
Rothwell, P. M. (2005). External validity of randomised controlled trials: "To whom do the results of this trial apply?" The Lancet, 365(9453), 82-93. https://doi.org/10.1016/S0140-6736(04)17670-8
Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., et al. (2007). Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Medicine, 4(10), e297. https://doi.org/10.1371/journal.pmed.0040297
Breastcancer.org. "Diversity in Clinical Trials." Breastcancer.org, 2024, [https://www.breastcancer.org/treatment/clinical-trials/diversity-in-trials](https://www.breastcancer.org/treatment/clinical-trials/diversity-in-trials). Accessed 26 Feb. 2025.
Pittell H, Calip GS, Pierre A, et al. Racial and Ethnic Inequities in US Oncology Clinical Trial Participation From 2017 to 2022. JAMA Netw Open. 2023;6(7):e2322515. doi:10.1001/jamanetworkopen.2023.22515
Otado, Jane et al. “Culturally Competent Strategies for Recruitment and Retention of African American Populations into Clinical Trials.” Clinical and translational science vol. 8,5 (2015): 460-6. doi:10.1111/cts.12285
Bodicoat, Danielle H et al. “Promoting inclusion in clinical trials-a rapid review of the literature and recommendations for action.” Trials vol. 22,1 880. 4 Dec. 2021, doi:10.1186/s13063-021-05849-7
